Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group
Authors:
- Tamara Pérez-JeldresTPTamara Pérez-Jeldres
- Paula Reyes-PérezPRPaula Reyes-Pérez
- Patricio Gonzalez-HormazabalPGPatricio Gonzalez-Hormazabal
- Cristóbal AvendanoCACristóbal Avendano
- Roberto Segovia MeleroRMRoberto Segovia Melero
- Lorena AzocarLALorena Azocar
- Veronica SilvaVSVeronica Silva
- Andres De La VegaAVAndres De La Vega
- Elizabeth ArriagadaEAElizabeth Arriagada
- Elisa HernandezEHElisa Hernandez
- Nataly AguilarNANataly Aguilar
- Carolina Pavez-OvalleCPCarolina Pavez-Ovalle
Open Access
- 15 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5741
Abstract
Extraintestinal manifestations (EIMs) significantly increase morbidity in inflammatory bowel disease (IBD) patients. In this study, we examined clinical and genetic factors associated with EIMs in 414 Latin IBD patients, utilizing machine learning for predictive modeling. In our IBD group (314 ulcerative colitis (UC) and 100 Crohn’s disease (CD) patients), EIM presence was assessed. Clinical differences between patients with and without EIMs were analyzed using Chi-square and Mann–Whitney U tests. Based on the genetic data of 232 patients, we identified variants linked to EIMs, and the polygenic risk score (PRS) was calculated. A machine learning approach based on logistic regression (LR), random forest (RF), and gradient boosting (GB) models was employed for predicting EIMs. EIMs were present in 29% (120/414) of patients. EIM patients were older (52 vs. 45 years, p = 0.01) and were more likely to have a family history of IBD (p = 0.02) or use anti-TNF therapy (p = 0.01). EIMs were more common in patients with CD than in those with UC without reaching statistical significance (p = 0.06). Four genetic variants were associated with EIM risk (rs9936833, rs4410871, rs3132680, and rs3823417). While the PRS showed limited predictive power (AUC = 0.69), the LR, GB, and RF models demonstrated good predictive capabilities. Approximately one-third of IBD patients experienced EIMs. Significant risk factors included genetic variants, family history, age, and anti-TNF therapy, with predictive models effectively identifying EIM risk.Keywords
Funding Information
- Comisión Nacional de Investigación Científica y Tecnológica (11220147, 698106, 399564)
- Comisión Nacional de Investigación Científica y Tecnológica (11220147, 698106, 399564)
This publication has 58 references indexed in Scilit:
- The Genetics of Inflammatory Bowel DiseaseMolecular Diagnosis & Therapy, 2023
- ACG Clinical Guideline: Management of Crohn's Disease in AdultsAmerican Journal of Gastroenterology, 2018
- Next-generation genotype imputation service and methodsNature Genetics, 2016
- Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared lociNature Genetics, 2016
- Differences in Inflammatory Bowel Disease Phenotype between South Asians and Northern Europeans Living in North West London, UKAmerican Journal of Gastroenterology, 2011
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease CohortAmerican Journal of Gastroenterology, 2011
- Distribution and Manifestations of Inflammatory Bowel Disease in Asians, Hispanics and African Americans: A Systematic ReviewAmerican Journal of Gastroenterology, 2009
- Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel diseaseNature Reviews Immunology, 2006
- National Cooperative Crohn's Disease Study: Extraintestinal manifestations and perianal complicationsGastroenterology, 1979